Novo Nordisk

NVO
Novo Nordisk

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world.

Founded
1923 (98 years)
CEO
Lars Fruergaard Jørgensen
Investor RelationsSEC
Revenue
20 billion (2020)

Want to see more? Sign up!